NCT00851370View on ClinicalTrials.gov

Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Omalizumab (Xolair)

Bi-weekly

DRUG

Placebo

Bi-Weekly

Trial Locations (1)

80206

National Jewish Health, Denver

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

National Jewish Health

OTHER